Institutional investors made a huge push into hedge funds following the bursting of the dot-com bubble. It was the perfect environment because you had a situation where expensive stocks crashed while cheap stocks were a wonderful hedge. Going long cheap and short expensive allowed them to win in both directions.1 The S&P 500 got clobbered … Read more
If there’s one thing I don’t recommend, it’s buying stock on margin. Due to the volatility of stocks and high margin interest rates, borrowing money to buy stocks is a bad idea. Conversely, I’m not opposed to buying a home on margin, namely through a mortgage, if buying follows a homebuying guideline like the 30/30/3 … Read more
By Thomas Kerr, CFA NASDAQ:CTSO READ THE FULL CTSO RESEARCH REPORT CytoSorbents (NASDAQ:CTSO) reported 2nd quarter 2024 outcomes on August thirteenth and the outcomes have been principally above our expectations. For the 2nd quarter of 2024, complete revenues elevated roughly 5.0% to $9.9 million. Complete product gross sales have been $8.8 million, a rise of … Read more
